The application of pathway inhibitors (FAK, Akt, and NF-κB) decreased the proliferation and anti-apoptosis effect of netrin-1 in AML cells, which were detected through CCK-8, flow cytometry, and western blotting. The gene discussed is AKT1; the disease is acute myeloid leukemia.